A panel of five experts discuss the implications of cancer heterogeneity for diagnostics and therapy.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures
Genome Medicine Open Access 16 December 2021
-
Large-scale patterning of single cells and cell clusters in hydrogels
Scientific Reports Open Access 01 March 2018
-
Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
Oncogene Open Access 31 October 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bhatia, S., Frangioni, J., Hoffman, R. et al. The challenges posed by cancer heterogeneity. Nat Biotechnol 30, 604–610 (2012). https://doi.org/10.1038/nbt.2294
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2294
This article is cited by
-
Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures
Genome Medicine (2021)
-
Large-scale patterning of single cells and cell clusters in hydrogels
Scientific Reports (2018)
-
Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
Oncogene (2017)
-
High-specificity detection of rare alleles with Paired-End Low Error Sequencing (PELE-Seq)
BMC Genomics (2016)
-
Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer
Oncogenesis (2015)